Sector Pharmaceuticals & Biotech. - Latest news, views and updates

Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets

IND

USA

Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding

Diary
NEWS
Reports

Pharmaceuticals & Biotech.

Sector

Watch

P

Pharmaceuticals & Biotech.

SECTOR | 08 Dec 2025, 02:12PM

HIV-free for seven years after cancer treatment, and doctors are amazed

Business Standard

A man treated for blood cancer has stayed HIV-free for seven years after a stem-cell transplant, even without the CCR5 mutation once seen as essential, shifting cure research

Copy LinkShare on

Share on Share on Share on

P

Pharmaceuticals & Biotech.

SECTOR | 05 Dec 2025

From hugs to food to tattoos: Debunking 16 dangerous myths about HIV

Business Standard

From casual contact and mosquito bites to tattoos, pregnancy, PrEP, and treatment, specialists debunk the misconceptions that fuel stigma and delay diagnosis

Copy LinkShare on

Share on Share on Share on

P

Pharmaceuticals & Biotech.

SECTOR | 04 Dec 2025

Pharmaceutical sector set to gain from rupee fall despite API dependence

Business Standard

Exporters like Sun Pharma, Dr Reddy's may see 7-8% revenue lift, yet margins pressured by high raw material import costs

Copy LinkShare on

Share on Share on Share on

P

Pharmaceuticals & Biotech.

SECTOR | 03 Dec 2025

How poor diabetes management increases complications in people with HIV

Business Standard

Experts warn that poor sugar control pushes HIV-related health risks higher, leading to faster progression of heart, kidney and nerve problems

Copy LinkShare on

Share on Share on Share on

P

Pharmaceuticals & Biotech.

SECTOR | 02 Dec 2025

Can HIV be cured? New research shows long-term remission may be closer

Business Standard

Early trial results show that combining antibodies and T-cells helped some people living with HIV maintain viral control for months without daily ART, raising cautious hope for long-term remission

Copy LinkShare on

Share on Share on Share on

How soon HIV symptoms appear, and why most people don't notice them

Business Standard | 02 Dec 2025 5 more

Datanomics: Injecting drug users remain at highest HIV risk in India

Business Standard | 01 Dec 2025

World AIDS Day 2025: India halves new HIV cases, AIDS deaths drop over 80%

Business Standard | 01 Dec 2025

World AIDS Day 2025: Theme, history, significance, facts you need to know

Business Standard | 01 Dec 2025

World AIDS Day 2025: Date, Theme, History, Significance And More

NDTV Profit | 01 Dec 2025

Overcoming disruption in the fight to end AIDS

Business Line | 01 Dec 2025

P

Pharmaceuticals & Biotech.

SECTOR | 02 Dec 2025

Dr Reddy's, Cipla, Biocon, Sun Pharma In Focus After WHO Issues Guideline On Use Of GLP-1 Drugs For Obesity

NDTV Profit

In September, the WHO added GLP-1 therapies to its Essential Medicines List for managing Type 2 diabetes in high-risk groups.

Copy LinkShare on

Share on Share on Share on

P

Pharmaceuticals & Biotech.

SECTOR | 01 Dec 2025

Birth control in HIV: What women can safely use and what doctors warn about

Business Standard

HIV-positive women have several safe birth-control options, but viral load, ART interactions, treatment stability still guide what doctors recommend for reliable contraception and partner protection

Copy LinkShare on

Share on Share on Share on

P

Pharmaceuticals & Biotech.

SECTOR | 28 Nov 2025

HIV Drug Lenacapavir Faces Delay In India: What Patients Need To Know

NDTV Profit

Lenacapavir is expected to transform HIV prevention significantly. Health experts call it a major step towards controlling the epidemic.

Copy LinkShare on

Share on Share on Share on

Generic versions of breakthrough HIV drug Lenacapavir still not available in India, say treatment activists

Business Line | 27 Nov 2025

P

Pharmaceuticals & Biotech.

SECTOR | 27 Nov 2025

Zydus To Export Medicines To Afghanistan, Establish Local Facility As India-Taliban Ties Improve

NDTV Profit

Zydus Life signed a memorandum of understanding worth $100 million with Kabul-based Raoufi Group in the UAE on Thursday.

Copy LinkShare on

Share on Share on Share on

P

Pharmaceuticals & Biotech.

SECTOR | 27 Nov 2025

Global HIV response in crisis due to severe funding collapse, warns UNAIDS

Business Standard

With HIV services shrinking across countries and prevention tools falling out of reach, UNAIDS says the world is at a critical juncture and must renew its commitment to end AIDS

Copy LinkShare on

Share on Share on Share on

more

loading

Trendlyne

Stay ahead of the market

Quick Links

Contact us

Blogs

FAQs

All Features

Markets Today

Nifty 50 today

Sensex today

Latest Quarterly results

FII & DII data today

Dashboard

Industry & Sector analysis

ETFs

Mutual Funds

Bullish & Bearish spread

Global Indices

Tools

Compare stocks

Widgets

Data Downloader

Excel Connect

IPOs

Dashboard (Mainboard & SME)

Upcoming IPOs

Recently Listed IPOs

Most Successful IPOs

Upcoming IPOs

Methodhub Software

K V Toys

Flywings Simulator Training

Company

Privacy

Terms of Use

Disclaimer

Trendlyne Products

Starfolio

SmartOptions

Trendlyne US Global

Get Mobile App

Android
iOS